-
公开(公告)号:US08183275B2
公开(公告)日:2012-05-22
申请号:US12311672
申请日:2007-10-16
申请人: Peter H. Dobbelaar , Christopher L. Franklin , Allan Goodman , Cheng Guo , Peter R. Guzzo , Mark Hadden , Shuwen He , Alan J. Henderson , Tianying Jian , Linus S. Lin , Jian Liu , Ravi P. Nargund , Megan Ruenz , Bruce J. Sargent , Iyassu K. Sebhat , Larry Yet
发明人: Peter H. Dobbelaar , Christopher L. Franklin , Allan Goodman , Cheng Guo , Peter R. Guzzo , Mark Hadden , Shuwen He , Alan J. Henderson , Tianying Jian , Linus S. Lin , Jian Liu , Ravi P. Nargund , Megan Ruenz , Bruce J. Sargent , Iyassu K. Sebhat , Larry Yet
IPC分类号: A61K31/4178 , A61K31/4164 , C07D471/04 , C07D401/10 , C07D403/10 , C07D233/64
CPC分类号: C07D401/10 , C07D233/64 , C07D403/10 , C07D403/12 , C07D405/04 , C07D409/10 , C07D413/06 , C07D417/06 , C07D417/10 , C07D471/04
摘要: Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.
-
公开(公告)号:US20100204236A1
公开(公告)日:2010-08-12
申请号:US12311672
申请日:2007-10-16
申请人: Peter H. Dobbelaar , Christopher L. Franklin , Allan Goodman , Cheng Guo , Peter R. Guzzo , Mark Hadden , Shuwen He , Alan J. Henderson , Tianying Jian , Linus S. Lin , Jian Liu , Ravi P. Nargund , Megan Ruenz , Bruce J. Sargent , Iyassu K. Sebhat , Larry Yet
发明人: Peter H. Dobbelaar , Christopher L. Franklin , Allan Goodman , Cheng Guo , Peter R. Guzzo , Mark Hadden , Shuwen He , Alan J. Henderson , Tianying Jian , Linus S. Lin , Jian Liu , Ravi P. Nargund , Megan Ruenz , Bruce J. Sargent , Iyassu K. Sebhat , Larry Yet
IPC分类号: A61K31/4178 , A61K31/4985 , A61K31/501 , A61K31/497 , A61K31/506 , A61K31/4439 , A61K31/427 , A61K31/425 , A61K31/4196 , A61K31/4164 , C07D471/04 , C07D401/10 , C07D417/10 , C07D405/10 , C07D403/10 , C07D409/06 , C07D233/64 , A61P9/10 , A61P3/04
CPC分类号: C07D401/10 , C07D233/64 , C07D403/10 , C07D403/12 , C07D405/04 , C07D409/10 , C07D413/06 , C07D417/06 , C07D417/10 , C07D471/04
摘要: Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.
-
公开(公告)号:US5580866A
公开(公告)日:1996-12-03
申请号:US424464
申请日:1995-05-03
IPC分类号: A61K31/55 , A61K31/554 , A61P25/08 , C07D281/10
CPC分类号: C07D281/10
摘要: Compounds of formula I ##STR1## in which n=0, 1 or 2;R.sub.1, R.sub.2, R.sub.6 and R.sub.7 independently represent H or alkyl (optionally substituted by one or more halo);R.sub.3 and R.sub.4 independently represent H or alkyl or together represent a group of formula .dbd.NR.sub.12 where R.sub.12 represents H, hydroxy, alkyl, phenyl or alkoxy; each alkyl, phenyl and alkoxy being optionally substituted with one or more halo;R.sub.5 represents: (a) H, (b) alkyl, (c) a group of formula --COR.sub.13 in which R.sub.13 is H, alkyl or phenyl, when R.sub.3 and R.sub.4 represent H or alkyl (optionally substituted with one or more halo), or (d) a group of formula --S(O).sub.p R.sub.14 in which p=1 or 2 and R.sub.14 is alkyl or phenyl, when R.sub.3 and R.sub.4 represent H or alkyl (optionally substituted with one or more halo); each alkyl and phenyl optionally substituted with one or more halo;and R.sub.8 to R.sub.11 independently represent H, halo, cyano, nitro, alkyl alkoxy, alkanoyl, carboxy, alkanoyloxy, carbamoyl (optionally substituted with alkyl or sulphamoyl (optionally substituted with alkyl of 1 to 4 carbon atoms); each alkyl, alkoxy, alkanoyl or alkanoyloxy optionally substituted with one or more halo;have utility in the treatment of seizures and/or neurological disorders such as epilepsy and/or as neuroprotective agents to protect against conditions such as stroke.
摘要翻译: PCT No.PCT / EP93 / 03123 Sec。 371日期:1995年5月3日 102(e)日期1995年5月3日PCT提交1993年11月6日PCT公布。 第WO94 / 11360号公报 日期:1994年5月26日公式I
I的化合物,其中n = 0,1或2; R1,R2,R6和R7独立地表示H或烷基(任选被一个或多个卤素取代); R3和R4独立地表示H或烷基或一起代表式= NR12的基团,其中R12表示H,羟基,烷基,苯基或烷氧基; 每个烷基,苯基和烷氧基任选被一个或多个卤素取代; R 5表示:(a)H,(b)烷基,(c)R 3为H,烷基或苯基的式-COR 13基团,当R 3和R 4表示H或烷基(任选被一个或多个卤素取代时) 或(d)当R 3和R 4表示H或烷基(任选被一个或多个卤素取代)时,其中p = 1或2且R 14为烷基或苯基的式-S(O)pR 14基团; 每个烷基和任选被一个或多个卤素取代的苯基; 并且R 8至R 11独立地表示H,卤素,氰基,硝基,烷基烷氧基,烷酰基,羧基,烷酰氧基,氨基甲酰基(任选被烷基或氨磺酰基(任选被1至4个碳原子的烷基取代)取代;各烷基,烷氧基,烷酰基 或任选被一个或多个卤素取代的烷酰氧基;可用于治疗癫痫发作和/或神经障碍,例如癫痫和/或作为神经保护剂以防止诸如中风的病症。 -
4.
公开(公告)号:US5519034A
公开(公告)日:1996-05-21
申请号:US244368
申请日:1994-08-18
IPC分类号: A61K31/47 , A61K31/472 , A61K31/4725 , A61P25/00 , A61P25/18 , A61P25/30 , C07D215/02 , C07D215/06 , C07D217/04 , C07D217/18 , C07D217/20 , C07D405/08
CPC分类号: C07D217/20 , C07D217/04 , C07D217/18
摘要: Tetrahydroisoquinoline compounds of formula I ##STR1## and pharmaceutically acceptable salts and lipophilic ester thereof have utility as analgesics and in the treatment of psychoses, Parinson's disease, Lesch-Nyan syndrome, attention deficit disorder or cognitive impairment or in the relief of drug dependence or tardive dyskinesia.
摘要翻译: PCT No.PCT / EP92 / 02900 Sec。 371日期:1994年8月18日 102(e)日期1994年8月18日PCT提交1992年12月12日PCT公布。 公开号WO93 / 13073 日本时间:1993年7月8日。式I的四氢异喹啉化合物及其药学上可接受的盐和亲脂性酯可用作止痛药和治疗精神病,帕金森氏病,莱斯奈恩综合征,注意力缺陷障碍或认知障碍或 缓解药物依赖或迟发性运动障碍。
-
公开(公告)号:US5047432A
公开(公告)日:1991-09-10
申请号:US541174
申请日:1990-06-20
IPC分类号: C07D307/52 , A61K31/135 , A61K31/16 , A61K31/165 , A61K31/215 , A61K31/22 , A61K31/33 , A61K31/4409 , A61K31/4418 , A61K31/445 , A61K31/535 , A61K31/5375 , A61P25/24 , A61P25/26 , C07C45/63 , C07C49/567 , C07C67/00 , C07C213/00 , C07C215/38 , C07C217/48 , C07C217/74 , C07C219/22 , C07C225/18 , C07C231/00 , C07C231/12 , C07C235/06 , C07C313/00 , C07C317/28 , C07C323/29 , C07D211/14 , C07D211/30 , C07D211/70 , C07D213/30 , C07D295/073 , C07D295/08 , C07D295/084 , C07D295/10 , C07D295/13 , C07D295/145 , C07D295/185 , C07D317/28 , C07D319/06
CPC分类号: C07D213/30 , C07C45/63 , C07C49/567 , C07D211/70 , C07D295/073 , C07D295/092 , C07D295/13 , C07D295/145 , C07D295/185 , C07D317/28
摘要: Compounds of formula I ##STR1## and pharmaceutically acceptable salts thereof; in which R.sub.1 and R.sub.2, which are the same or different, are H or an optionally substituted hydrocarbon group or R.sub.1 and R.sub.2 together with the nitrogen atom to which they are attached form an optionally substituted heterocyclic ring;R.sub.3 is an optionally substituted aromatic hydrocarbon group; andR.sub.4 is a hydrocarbon group containing at least one substituent selected from the group consisting of hydroxy and acylated derivatives thereof, optionally substituted alkoxy groups, optionally substituted cycloalkyloxy groups, optionally substituted alkylenedioxy groups, oxo and groups of formula S(O).sub.p R.sub.5 in which p is 0, 1 or 2 and R.sub.5 is an alkyl group, said hydrocarbon group being optionally substituted by additional substituents,are useful in the treatment of depression.
-
公开(公告)号:US4925879A
公开(公告)日:1990-05-15
申请号:US227869
申请日:1988-08-01
IPC分类号: C07D307/52 , A61K31/135 , A61K31/16 , A61K31/165 , A61K31/215 , A61K31/22 , A61K31/33 , A61K31/4409 , A61K31/4418 , A61K31/445 , A61K31/535 , A61K31/5375 , A61P25/24 , A61P25/26 , C07C45/63 , C07C49/567 , C07C67/00 , C07C213/00 , C07C215/38 , C07C217/48 , C07C217/74 , C07C219/22 , C07C225/18 , C07C231/00 , C07C231/12 , C07C235/06 , C07C313/00 , C07C317/28 , C07C323/29 , C07D211/14 , C07D211/30 , C07D211/70 , C07D213/30 , C07D295/073 , C07D295/08 , C07D295/084 , C07D295/10 , C07D295/13 , C07D295/145 , C07D295/185 , C07D317/28 , C07D319/06
CPC分类号: C07D213/30 , C07C45/63 , C07C49/567 , C07D211/70 , C07D295/073 , C07D295/092 , C07D295/13 , C07D295/145 , C07D295/185 , C07D317/28
摘要: Compounds of formula I ##STR1## and pharmaceutically acceptable salts thereof; in which R.sub.1 and R.sub.2, which are the same or different, are H or an optionally substituted hydrocarbon group or R.sub.1 and R.sub.2 together with the nitrogen atom to which they are attached form an optionally substituted heterocyclic ring;R.sub.3 is an optionally substituted aromatic hydrocarbon group; andR.sub.4 is a hydrocarbon group containing at least one substituent selected from the group consisting of hydroxy and acylated derivatives thereof, optionally substituted alkoxy groups, optionally substituted cycloalkyloxy groups, optionally substituted alkylenedioxy groups, oxo and groups of formula S(O).sub.p R.sub.5 in which p is 0, 1 or 2 and R.sub.5 is an alkyl group, said hydrocarbon group being optionally substituted by additional substituents,are useful in the treatment of depression.
摘要翻译: 式I化合物及其药学上可接受的盐; 其中相同或不同的R 1和R 2为H或任选取代的烃基或R 1和R 2与它们所连接的氮原子一起形成任选取代的杂环; R3是任选取代的芳族烃基; 并且R 4是含有至少一个选自羟基和其酰化衍生物,任选取代的烷氧基,任选取代的环烷氧基,任选取代的亚烷基二氧基,氧代和式S(O)p R 5基团的取代基的烃基,其中 p为0,1或2,R5为烷基,所述烃基任选被其它取代基取代,可用于治疗抑郁症。
-
公开(公告)号:US08450307B2
公开(公告)日:2013-05-28
申请号:US11628569
申请日:2005-06-06
申请人: Bruce J. Sargent , Henry Pauls , Judd M. Berman , Jailall Ramnauth , Peter Sampson , Andras Toro , Fernando J. Martin , Matthew D. Surman , Helene Y. Decornez , David D. Manning
发明人: Bruce J. Sargent , Henry Pauls , Judd M. Berman , Jailall Ramnauth , Peter Sampson , Andras Toro , Fernando J. Martin , Matthew D. Surman , Helene Y. Decornez , David D. Manning
IPC分类号: C07D401/12 , C07D405/12 , C07D409/12 , C07D498/04 , A61K31/551 , A61K31/5365
CPC分类号: C07D498/04 , C07D401/12 , C07D405/12 , C07D409/12 , C07D471/04 , C07D471/14
摘要: In part, the present invention is directed to antibacterial compounds.
摘要翻译: 部分地,本发明涉及抗菌化合物。
-
公开(公告)号:US20100093705A1
公开(公告)日:2010-04-15
申请号:US11628569
申请日:2005-06-06
申请人: Bruce J. Sargent , Henry Pauls , Judd M. Berman , Jailall Ramnauth , Peter Sampson , Andras Toro , Fernando J. Martin , Matthew D. Surman , Helene Y. Decornez , David D. Manning
发明人: Bruce J. Sargent , Henry Pauls , Judd M. Berman , Jailall Ramnauth , Peter Sampson , Andras Toro , Fernando J. Martin , Matthew D. Surman , Helene Y. Decornez , David D. Manning
IPC分类号: A61K31/551 , C07D471/04 , C07D223/16 , C07D491/02 , A61K31/4375 , A61P31/04
CPC分类号: C07D498/04 , C07D401/12 , C07D405/12 , C07D409/12 , C07D471/04 , C07D471/14
摘要: In part, the present invention is directed to antibacterial compounds.
摘要翻译: 部分地,本发明涉及抗菌化合物。
-
-
-
-
-
-
-